MNG977
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG1042 | — | — | 0.785 |
| 2 | SRR12202455 | — | — | 0.769 |
| 3 | MNG951 | — | — | 0.743 |
| 4 | MNG1037 | — | — | 0.735 |
| 5 | MNG70 | — | — | 0.728 |
| 6 | SRR23303735 | — | — | 0.724 |
| 7 | MNG451 | — | — | 0.721 |
| 8 | MNG1043 | — | — | 0.717 |
| 9 | MNG910 | — | — | 0.714 |
| 10 | SRR23303762 | — | — | 0.710 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 20 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| TGF_BETA_SIGNALING | 0.306 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.276 | Idelalisib | — uncovered |
| MYC_TARGETS_V1 | 0.236 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.203 | Remibrutinib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.202 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.150 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.138 | Idelalisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.134 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.123 | Remibrutinib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.119 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.110 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.098 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.066 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.052 | Idelalisib | — uncovered |
| P53_PATHWAY | 0.050 | Idelalisib | — uncovered |
| UV_RESPONSE_UP | 0.045 | Idelalisib | — uncovered |
| HEME_METABOLISM | 0.044 | Temsirolimus | — uncovered |
| APOPTOSIS | 0.039 | Idelalisib | — uncovered |
| PEROXISOME | 0.027 | Idelalisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.025 | Idelalisib | — uncovered |